| Product NDC: | 60575-515 |
| Proprietary Name: | CODAR |
| Non Proprietary Name: | Codeine Phosphate, Pseudoephedrine Hydrochloride |
| Active Ingredient(s): | 8; 30 mg/5mL; mg/5mL & nbsp; Codeine Phosphate, Pseudoephedrine Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 60575-515 |
| Labeler Name: | Respa Pharmaceuticals |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part341 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20110713 |
| Package NDC: | 60575-515-16 |
| Package Description: | 473 mL in 1 BOTTLE (60575-515-16) |
| NDC Code | 60575-515-16 |
| Proprietary Name | CODAR |
| Package Description | 473 mL in 1 BOTTLE (60575-515-16) |
| Product NDC | 60575-515 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Codeine Phosphate, Pseudoephedrine Hydrochloride |
| Dosage Form Name | LIQUID |
| Route Name | ORAL |
| Start Marketing Date | 20110713 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Respa Pharmaceuticals |
| Substance Name | CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE |
| Strength Number | 8; 30 |
| Strength Unit | mg/5mL; mg/5mL |
| Pharmaceutical Classes |